Introduction
Klebsiella pneumoniae is an opportunistic bacterial pathogen and is responsible for diverse hospital-acquired infections in immunocompetent and immunocompromised patients. The major infections caused by K. pneumoniae are pneumonia and complicated urinary tract infections [1, 2] , and these infections have distressing mortality rates in all age groups, particularly in infants. Furthermore, K. pneumoniae remains one of the major biofilm-forming nosocomial pathogens [3, 4] . Biofilms are the crucial factors responsible for the evolution of multidrug-resistant strains, and although antibiotics can easily suppress the development of bacterial cells in blood, they cannot infiltrate the surfaceassociated biofilms produced by the same organisms [5, 6] .
K. pneumoniae is known to secrete a variety of β-lactamases, which inactivate the majority of β-lactam antibiotics, and extended spectrum β-lactamases (ESBLs) constitute an intensifying threat in several healthcare sectors [6] . The vast majority of ESBLs secreted by K. pneumoniae are of the TEM (Temoniera) and lineages SHV-1 (sulfhydryl variable of TEM) [7] . Reports have also shown a strong correlation between biofilm formation and β-lactamases production by certain bacterial species, including ESBL-producing K. pneumoniae, Escherichia coli, and Pseudomonas aeruginosa [8, 9] . Furthermore, it has been shown that SHV-1 β-lactamase positive K. pneumoniae and Proteus mirabilis strains efficiently form biofilms on various abiotic surfaces [10] . The inherent ability of K. pneumoniae to form intricate biofilms on living and non-living surfaces poses a substantial threat. Capsule formation, which is controlled by the treC and sugF genes, also plays a vital role in the pathogenesis of K. pneumoniae infections as they shield the pathogen from host defense systems [11] . These genes control biofilm formation by K. pneumoniae by modulating capsular polysaccharide (CPS) production [12] . Type 3 fimbriae, a protein encoded by the mrk operon, is a crucial factor responsible for biofilm formation by K. pneumoniae [3, 13] , and the protein plays a vital role in bacterial adhesion and biofilm formation on biotic and abiotic surfaces [12] [13] [14] [15] . Furthermore, it has been established that the biofilmforming ability of K. pneumoniae is controlled by the luxSdependent quorum sensing (QS) system [4] .
Because of the increasing complexities of most microbial infections and resistance to conventional therapy, alternative therapies are required, and screening for small molecules that inhibit the attachment and biofilm formation. Hence, the present study was performed to investigate the effects of Arctium lappa Linn. (Burdock) root, a popular, healthy, and nourishing dietary food consumed by the majority of people in Asia, especially Japan, Korea, Thailand, and Taiwan [16] , and its major component, chlorogenic acid (CGA), on biofilm formation and the expressions of genes associated with biofilm formation by K. pneumoniae.
Materials and Methods

Bacterial Strains
The clinical isolates of K. pneumoniae were generous gifts from Sanghamitra Hospital, Pongola, Andhra Pradesh, India. Background information about the microbial strains used in the study is provided in Table 1 . The reference strain of K. pneumoniae MTCC 432 was obtained from Microbial Type Culture Collection (MTCC), Institute of Microbial Technology (IMTECH), Chandigarh, India, and K. pneumoniae KCCM 2619 and KCCM 42750 were purchased from Korean Culture Center of Microorganisms (KCCM). K. pneumoniae was cultured in nutrient broth (NB) (HiMedia, India) and used for all the assays.
Plant Material and Pure Chlorogenic Acid
The collection and authentication of Burdock roots used were as previously described [17] . Roots were dried, ground to a powder, and the powder (50 g) was extracted with 500 ml of methanol for 48 h. Solvent was recovered using a rotary vacuum evaporator, and the semisolid mass obtained was concentrated under reduced pressure and stored in an air-tight container. Pure CGA was purchased from Sigma-Aldrich (USA).
Biofilm Inhibition Assays
Burdock root extract (BRE) (20-200 μg/ml) or CGA (0.028-0.28 mmol/l) were added to the NB medium supplemented with 0.5% glucose and inoculated with 1% bacterial inoculums. Biofilm growth and crystal violet quantification were performed as previously described [18] . K. pneumoniae biofilms grown on glass slides (10 mm diameter) were stained with 0.4% crystal violet and imaged under an optical microscope at 40×magnification (Nikon Eclipse Ti 100, Japan).
Pre-Formed Biofilm Disruption Assay
The potential of BRE to disrupt biofilms was assessed using an established procedure [19] . K. pneumoniae biofilms were initially grown in 24-well microtiter plates at 37°C for 24 h. The wells were then washed with distilled water, and the biofilms were then incubated at 37°C for 24 h with fresh medium containing BRE (100 μg/ml). Non-treated controls were run simultaneously. The wells were then washed, stained with 0.4% crystal violet, and the optical densities were measured at 570 nm. Percent biofilm disruption was calculated using the following formula: % Biofilms disruption = [(Control OD 570 nm -test OD 570 nm)/control OD 570 nm] × 100.
Confocal Laser Scanning Microscopy (CLSM) Analysis
For CLSM analysis, static biofilms grown on 1 cm 2 glass slides (control and treated) were stained with 0.1% acridine orange (a Table 1 . Background information on microbial strains used in this study.
Microorganisms
Collection Accession No. Source DNA binding fluorescent dye) and biofilm surface areas were determined using an argon-ion laser system at an excitation wavelength of 488 nm and emission wavelength of 500-550 nm under a Zeiss LSM710 confocal laser scanning microscope (Carl Zeiss, Germany) at 200×magnification.
QS Inhibition Assays
Chromobacterium violaceum (ATCC 12472) and Serratia marcescens (MTCC 97) were used for screening the anti-QS activity of CGA. Violacein pigment (purple) production by C. violaceum and prodigiosin pigment (red) production by S. marcescens are under the control of QS systems, and hence, loss of pigment reflects a quorum quenching effect [20] [21] [22] . The assay was performed by inoculating 1% of C. violaceum in a 24-well polystyrene plate containing 1 ml of NB medium with or without CGA (0-80 μg/ml). The plates were then incubated for 24 h at 30°C. S. marcescens (1% inoculums containing ~10 5 CFU) grown in 24-well polystyrene plates with or without CGA (0-0.225 mmol/l) in NB medium for 24 h were phenotypically visualized for the production of red prodigiosin pigment [18] .
Molecular Docking with β-Lactamase
Docking studies were performed to examine interactions between CGA and β-lactamase. SHV-1 is the β-lactamase secreted by most K. pneumoniae, and thus, the crystal structure of SHV-1 (DOI: 10.2210/pdb1shv/pdb) was retrieved from the RCSB Protein Data Bank and prepared using a Protein Preparation Wizard. Ligands were retrieved from PubChem Compound (NCBI) and prepared using LigPrep software (Schrodinger 9.3). A grid was generated at close proximity to the ligand, and docking was executed using the Glide (grid-based ligand docking with energetic) module of Schrodinger 9.3 (XP model). Interactions were visualized using PyMOL viewer.
Micro-Iodimetric Assay for Anti-β-Lactamase Activity β-Lactamase-producing K. pneumoniae was used to study the anti-β-lactamase activity of BRE and CGA. K. pneumoniae was grown overnight at 37°C in NB supplemented with amoxicillin to induce β-lactamase secretion. Cells were harvested, resuspended in phosphate buffer (pH 7), and lysed using an ultrasonicator.
Lysates were centrifuged and the cell free extract (CFE), which contained enzymes, was used for further assays [23] . A microiodimetric assay was used to determine the β-lactamase activity of CFE (50, 100, 150, or 200 μl) using amoxicillin as substrate as previously described [24] . The experiments were carried out after pre-incubating CFE with BRE and CGA separately in starchiodine solution to determine anti-β-lactamases activities. Clavulanic acid (30 μg) was used as a standard inhibitor. The optical densities of starch-iodine solutions were measured at 630 nm using a microplate reader (Rayto, China).
Quantitative Real-Time PCR (qRT-PCR) Assays
qRT-PCR was performed as previously described [25] . Planktonic cells of K. pneumoniae treated with CGA (0.19 mmol/l) or BRE (100 μg/ml) were used to access gene expression changes. Bacterial cells (1.5 ml) grown in NB at 37°C were harvested by centrifugation at 14,100 ×g for 5 min. Cell pellets were resuspended in 1 ml of Trizol reagent (Invitrogen, USA) and total RNA was isolated according to the manufacturer's instructions (Invitrogen, USA). cDNA was synthesized using a cDNA synthesis kit (Takara, USA) and real-time PCR (Applied Biosystems, USA) was used for gene amplification and relative quantification. Quantitative values of expression were determined using the delta-delta C t method and normalized with respect to the reference gene. SYBR Green Master mixes and AmpErase UNG were used for the relative quantification of mRNA levels using 16S rRNA as the reference gene. Amplifications were performed using the instrument's programmed two-step real-time PCR cycling conditions, followed by melt curve analysis. The total reaction volume (20 μl) in PCR tubes contained 10 μl of 2× USB VeriQuest Fast SYBR Green qPCR master mix (Affymetrix, Inc., USA), 1 μl of forward primer, 1 μl of reverse primer (10 pmol), 1 μl of template cDNA, and 7 μl of PCR water (MO-BIO, Inc., USA). The primer sequences used in this study are listed in Table 2 .
Statistical Analysis
The experiments were performed in duplicates and values are expressed as the mean ± SD. Statistical significance was determined by pair-wise testing using the t-test, and statistical significance was accepted for p values < 0.05. 
Results and Discussion
The inhibitory effect of BRE (0, 20, 40, 60, or 100 μg/ml) on biofilm formation by the four K. pneumoniae strains, described in Table 1 , were investigated. Results revealed dose-dependent inhibition of the K. pneumoniae biofilms, with maximum inhibition (~80%) at a concentration of 100 μg/ml (Fig. 1A) . BRE at 100 μg/ml showed maximum inhibition of biofilm formation of the K. pneumoniae isolates and reference strain tested, and this concentration was considered as the biofilm inhibitory concentration (BIC), the lowest concentration that produced visible disruption of biofilm formation and a significant reduction in the readings when compared with the control wells at OD 5 7 0 n m [26] . The ability of BRE to disrupt pre-formed biofilms was tested at its BIC. Pre-existing biofilms of all four K. pneumoniae strains were found to be significantly disrupted (~90%) (Fig. 1B) . The above results signify that BRE had both preventive and therapeutic effects against various K. pneumoniae strains. Microscopic images revealed that BRE at 100 μg/ml reduced the biofilm surface area on glass slides versus the non-treated control. Light microscopic images demonstrated that BRE prevented cells from regrouping, thus confirming its antibiofilm potential. All tested strains showed significant declines in biofilm surface area both quantitatively and subjectively (Fig. 1C) .
Concurrently, experiments were conducted with CGA (a component of BRE). All tested strains displayed a significant reduction in K. pneumoniae biofilm formation (p < 0.05) ( Fig. 2A) but showed no reduction of planktonic cell growth when CGA was treated at 0.19 mmol/l (Fig. 2B) . CLSM images also demonstrated considerable reductions of biofilm surface areas on CGA-treated slides versus the non-treated samples (Fig. 2C) . The growth of two K. pneumoniae strains were tested in the presence of CGA (0.28 mmol/l) and BRE (100 μg/ml), which confirmed that (A) Effect of BRE (20-100 μg/ml) on biofilm formation by K. pneumoniae strains. The graph illustrates the mean ± SEM of n = 3 experiments. *p < 0.05 and ** p < 0.01. (B) Disassembly effect of BRE (100 μg/ml) on pre-formed K. pneumoniae biofilms. (C) Microscopic images of K. pneumoniae biofilms in the presence and absence of BRE (100 μg/ml) (scale bar represents 20 μm).
K. pneumoniae growth was not affected at the tested concentrations (Figs. 2D and 2E) .
To understand the association between biofilm formation and β-lactamase production in K. pneumoniae, further study was extended to study the β-lactamase inhibitory activity of CGA. β-Lactamases are enzymes that confer antibiotic resistance in bacteria by hydrolyzing the β-lactam antibiotics. A strategy to prevent this resistant mechanism is to combine β-lactamase inhibitors like tazobactam, sulbactam, and clavulanic acid along with β-lactam antibiotics [27, 28] .
SHV are class-A-type β-lactamases that are universal and frequently found in K. pneumoniae isolates [29] . The study on interactions of SHV and β-lactamase inhibitors is high priority, as this might assist in designing and developing new SHV inhibitors. In vitro assays with CFE containing the enzyme were shown to lower the absorbance of amoxillin (substrate) in a time-dependent manner, indicating the enzyme activity and substrate cleavage. Interestingly, addition of CGA and BRE to the CFE prevented the enzymatic cleavage of the substrate (Fig. 3) , thus displaying a β-lactamase inhibitory effect.
Further, molecular docking was performed to study the binding efficiency of CGA with the crystal structure of SHV-1 β-lactamase. Interactions were analyzed using the binding energy scores (GlideScores) and numbers of active hydrogen bonds. CGA was found to an effectual inhibitor of SHV-1 with a high (negative) interaction energy (-12.055 kcal/mol) (Fig. 4A ) compared with the SHV-1-tazobactum complex (-3.954 kcal/mol) (Fig. 4B) and SHV-1-clavulanic acid complex (-4.140 kcal/mol) (Fig. 4C ). Higher (negative) energy is an indicator of rigid interactions of docked enzyme-inhibitor complexes. The docking scores of the standard inhibitors were matched with a previous report [30] . The interaction of the ligands with SHV-1 was principally assigned to side-chain hydrogen bonds with the Threonine 235 and Arginine 244 of SHV-1 (Fig. 4D) . The SHV-1-CGA complex was further stabilized by two backbone hydrogen bonds with Asparagine 276 and Isoleucine 279 (Fig. 4E) . The 16 hydrophobic and 3 polar amino acids surrounding the binding pocket of CGA suggested that Van der Waal's interactions are the main stabilizing factors involved.
Additionally, experiments were performed to screen the anti-QS activities of CGA, considering the fact that QS is a dynamic factor that synchronizes with biofilm formation, and these two processes are closely interrelated [31, 32] . Previously, we reported the anti-QS effects of BRE on C. violaceum and S. marcescens [18] , and hence, in the present study, the QS inhibitory effect of CGA was investigated by examining its ability to inhibit the production of QS controlled pigment production by C. violaceum and S. marcescens. Purple pigment produced by C. violaceum was completely inhibited by CGA at above 0.16 mmol/l. CGA also completely inhibited red prodigiosin pigment production by S. marcescens at the same concentrations (Fig. 5A) . Moreover, CGA did not inhibit planktonic growth at these concentrations (data not shown).
The expression levels of biofilm-related genes were analyzed by qRT-PCR assays. Of the genes tested (luxS, mrkD, and treC), the luxS gene (S-ribosylhomocysteinase) plays a vital role in the initial stages of K. pneumoniae biofilm development [33] . Protein LuxS catalyzes cleavage of the thioether linkage in S-ribosylhomocysteine to produce homocysteine and 4,5-dihydroxy-2,3-pentanedione, the precursor of type II bacterial autoinducer (AI-2). In K. pneumoniae, biofilm formation is modulated by a QS system that is controlled by the synthesis of AI-2. Hence, repression of luxS will result in low levels of AI-2 secretion, thus leading to quorum sensing inhibition [34] . mrkD (Type 3 fimbriae) and treC (trehalose-6-phosphate hydrolase) are candidate genes linked with biofilm formation in K. pneumoniae. mrkD has been shown to promote strong biofilm formation, enabling surface adhesion [12] , whereas treC plays a positive role in biofilm formation, initial adhesion, surface colonization, and dispersion [35] .
These three candidate genes, which are essential for biofilm formation by K. pneumoniae, were generally downregulated when K. pneumoniae cultures were treated with BRE and CGA. Specifically, BRE at its BIC downregulated the mRNA transcript levels of mrkD (50-fold), luxS (2-fold), and treC (1.6 fold) in K. pneumoniae (Fig. 5B) . mrkD and treC also displayed a repressive pattern after CGA treatment (0.19 mmol/l) (mrkD by 200-fold and treC by 5-fold) (Fig. 5C ), whereas luxS was relatively unaffected (1.25-fold decrease) in CGA-treated bacterial cultures, which ruled out the possibility of QS-mediated biofilm inhibition by CGA; hence, our finding reinforces the notion that biofilm inhibition by CGA is independent of the LuxS QS system. Repression of these biofilm-related genes in the cultures of K. pneumoniae showed that BRE and CGA prevent the formation of biofilms on inert surfaces by lowering the expression of mrkD and treC, which are involved in biofilm formation, but not of luxS, which is involved in QS.
It was also previously shown that the BRE prevented the biofilm formation and inhibited the QS controlled phenotypes in selected uropathogens; namely, S. marcescens, E. coli, and P. mirabilis [18] . The extract of burdock also possessed some antibacterial activities against Enterococcus faecalis, Fig. 3 . In vitro anti-β-lactamase activities of Burdock root extract (BRE) and chlorogenic acid (CGA).
BRE (100 μg/ml), CGA (0.19 mmol/l), and clavulanic acid (30 μg/ml, the positive control) displayed a consistent decline in OD values, signifying the enzymatic degradation of the substrate amoxicillin by the cell-free extract (CFE).
Staphylococcus aureus, P. aeruginosa, and Bacillus subtilis [36, 37] . CGA is a bioactive small molecule known for its antibacterial activity against S. aureus, Streptococcus pneumoniae, B. subtilis, E. coli, Shigella dysenteriae, and Salmonella typhimurium [38] . It was also shown that CGA was effective against Stenotrophomonas maltophilia and S. aureus biofilms [39, 40] . This study reports that CGA inhibits biofilm formation of K. pneumoniae strains without affecting the planktonic cell growth (minimum inhibitory concentration < 2.25 mmol/l).
Furthermore, the effect of CGA on different bacterial and yeast pathogens was tested. Interestingly, the growth of all four microbes was not altered at 0.056 and 0.28 mmol/l of CGA, but there was a significant difference Effect of CGA on growth and biofilms of E. coli BW25113 (A), C. albicans DAY185 (B), S. aureus ATCC 6538 (C), and P. aeruginosa PAO1 (D). *p < 0.05. in the biofilm formation, particularly in E. coli and C. albicans. Approximately 50% and 71% of the biofilm cells were reduced in E. coli treated with 0.056 and 0.28 mmol/l of CGA, respectively (Fig. 6A) . A 50% decline in C. albicans biofilms was also noted at 0.28 mmol/l of CGA (Fig. 6B) , whereas S. aureus and P. aeruginosa biofilms were resilient at the tested concentrations (Figs. 6C and 6D ).
In conclusion, the study demonstrates for the first time the antibiofilm and anti-β-lactamase activities of CGA against recalcitrant K. pneumoniae. mRNA profiling and in silico docking results were in line with the biofilm inhibitory effects of CGA. Although the mechanism of biofilm inhibition was only partially elucidated, our observations indicate that CGA probably has diverse antipathogenic potential.
